Navigation Links
Rigel to Present at Two Upcoming Investor Conferences
Date:8/25/2011

SOUTH SAN FRANCISCO, Calif., Aug. 25, 2011 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that James M. Gower, chairman and chief executive officer, and Ryan Maynard, executive vice president and chief financial officer of Rigel, will present at two separate investor conferences in September. Details of the events are as follows:Stifel Nicolaus Healthcare Conference 2011Date: Thursday, September 8th at 10:20 a.m. ETLocation: Boston, MASpeaker: James M GowerUBS Global Life Sciences ConferenceDate: Tuesday, September 20th at 1:30 p.m. ETLocation: New York, NYSpeaker: Ryan MaynardBoth presentations will be webcast.  To access the live audio webcast or subsequent archived recording, log on to www.rigel.com.  Please connect to Rigel's website several minutes prior to the start of the live webcast to ensure adequate time for any software download that may be necessary.

About Rigel (www.rigel.com)Rigel is a clinical-stage drug development company that discovers and develops novel, small-molecule drugs for the treatment of inflammatory and autoimmune diseases, as well as muscle disorders. Rigel's pioneering research focuses on intracellular signaling pathways and related targets that are critical to disease mechanisms. Rigel's productivity has resulted in strategic collaborations with large pharmaceutical partners to develop and market its product candidates. Current product development programs include fostamatinib, an oral syk inhibitor that has started its Phase 3 clinical trial program for rheumatoid arthritis, and R343, an inhaled syk inhibitor that has completed Phase 1 trials for asthma.

Contact: Ryan Maynard
Phone: 650.624.1284
Email: invrel@rigel.com


'/>"/>

SOURCE Rigel Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Rigel to Present at Wells Fargo Securities Healthcare Conference
2. Rigel to Present at Jefferies Global Healthcare Conference
3. Rigel Announces Pricing of Public Offering of Common Stock
4. Rigel Announces Proposed Public Offering of Common Stock
5. Rigel to Present at Bank of America Merrill Lynch Health Care Conference
6. Rigel Announces First Quarter Financial Results
7. Rigel Announces Fourth Quarter and Year End 2010 Financial Results
8. Rigel to Present at Three Upcoming Investor Conferences
9. Rigel Announces Participation at Two Investor Conferences
10. Rigel to Present at JP Morgan Healthcare Conference
11. Rigel Announces Third Quarter 2009 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... , March 29, 2017   Dynatronics ... today the appointment of Cynthia L. McHenry ... will be responsible for leading Dynatronics manufacturing, distribution, ... will report to Dynatronics, CEO Kelvyn H. ... concludes an extensive search process conducted by the ...
(Date:3/29/2017)... -- FinancialBuzz.com News Commentary  ... Data published in a research report by Grand View Research, Inc., ... USD 55.8 billion by 2025. The projection takes into consideration the continuous ... a more open approach towards cannabis products around the world. In 2016, ... North Dakota , Ohio , and ...
(Date:3/28/2017)... 2017 The global emerging cancer diagnostics market ... from 2016 to 2023 and reach a figure of ... is a chronic disease and is affecting a huge ... market. This report is focused on emerging cancer diagnostics ... is propelled due to factors such as: increasing number ...
Breaking Medicine Technology:
(Date:3/28/2017)... ... 2017 , ... The Thyroid Secret is a specialized 9-part ... program was recently launched on March 1, and Dr. Wentz discussed varied benefits ... Dr. Izabella Wentz is a licensed pharmacist and a foremost thyroid specialist. After ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... science and clinical practice of radiosurgery, announced today the publication of a ... registry established to standardize data collection from patients treated with stereotactic radiosurgery ...
(Date:3/28/2017)... ... ... WHO: , Dr. Paul Thomas; Dr. Brian Hooker; Dr. Judy Mikovits; Dr. ... will speak to the press on behalf of over 200 doctors, scientists, and scientific ... commission. , WHERE: , Zenger Room, National Press Club, 529 14th Street NW, ...
(Date:3/28/2017)... Calif. (PRWEB) , ... March 28, 2017 , ... ... its leading physicians, Paul Yost, will begin serving as new board chair for ... this month. Yost will serve the remainder of soon-to-be former chair Mark Refowitz’s ...
(Date:3/28/2017)... ... March 28, 2017 , ... METTLER ... ions found in power plant water and steam. , Chlorides and sulfates cause ... boilers, leading to extensive maintenance and unplanned shutdowns. Monitoring these ions at low ...
Breaking Medicine News(10 mins):